These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16511380)

  • 1. Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule.
    Rietveld E; Vergouwe Y; Steyerberg EW; Huysman MW; de Groot R; Moll HA;
    Pediatr Infect Dis J; 2006 Mar; 25(3):201-7. PubMed ID: 16511380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age.
    Stensballe LG; Fullarton JR; Carbonell-Estrany X; Simões EA
    Pediatr Infect Dis J; 2010 Apr; 29(4):374-6. PubMed ID: 20016397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
    Madhi SA; Kuwanda L; Cutland C; Klugman KP
    J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].
    Bergsträsser E; Zbinden R; Minder C; Gnehm HE
    Klin Padiatr; 1998; 210(6):418-21. PubMed ID: 9871899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada.
    Paes B; Cole M; Latchman A; Pinelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2191-6. PubMed ID: 19604126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain].
    Figueras-Aloy J; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    An Pediatr (Barc); 2009 Jul; 71(1):47-53. PubMed ID: 19524492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiratory syncytial virus prophylaxis among preterm infants--four seasons' experience].
    Klimek M; Kwinta P; Kruczek P; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):34-8. PubMed ID: 19485253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.
    Boyce TG; Mellen BG; Mitchel EF; Wright PF; Griffin MR
    J Pediatr; 2000 Dec; 137(6):865-70. PubMed ID: 11113845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants.
    Greenough A; Alexander J; Boit P; Boorman J; Burgess S; Burke A; Chetcuti PA; Cliff I; Lenney W; Lytle T; Morgan C; Raiman C; Shaw NJ; Sylvester KP; Turner J
    Thorax; 2009 Jun; 64(6):490-5. PubMed ID: 19213770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation.
    Sampalis JS; Langley J; Carbonell-Estrany X; Paes B; O'Brien K; Allen U; Mitchell I; Aloy JF; Pedraz C; Michaliszyn AF
    Med Decis Making; 2008; 28(4):471-80. PubMed ID: 18556643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
    Cabalka AK
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
    Medici MC; Arcangeletti MC; Merolla R; Chezzi C;
    Acta Biomed; 2004 Apr; 75(1):26-33. PubMed ID: 15315084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.